BHVN
Biohaven Ltd.stockNYSE
At CloseNov 18, 2026 3:59:56 PM EST
12.90USD-2.530%(-0.34)2,323,927
Pre-marketNov 18, 2026 8:41:30 AM EST
13.25USD+0.076%(+0.01)
After-hoursNov 18, 2026 4:10:30 PM EST
12.90USD-0.039%(-0.01)
Loading…
Loading…
1.95B
Healthcare
Biotechnology
HQ
New Haven, CT, USA
Previous Close
$13.24
Beta
1.36
52-Week High
$18.24 2026-08-26
52-Week Low
$8.03 2026-03-30
SMA 50
$13.41
SMA 200
$12.35
Avg. Vol 10D
2.20M
Avg. Vol 30D
3.19M
Avg. Vol 90D
2.84M
Relative Vol
0.73
151.06M
128.57M
85.11%
15,012,928
11.68%
2.94
59%/41%
43.73%
32.17%
0.4300%
10,000,000
71
-542.7M
-3.81
-473.2M
940.46
Nov 5, 2026
Biohaven advances Graves’ disease drug trial, presents research ·
Investing.com
Nov 3, 2026
Oct 29, 2026
Biohaven Q3 Loss Narrows as FDA Accepts Vyglxia NDA Resubmission ·
Securities.io
BHVN Profile
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
BHVN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 14.07 | 2026-11-12 | -8.24% | -1.107 |
| 1M | 11.35 | 2026-10-19 | +13.74% | 1.323 |
| 3M | 14.14 | 2026-08-19 | -8.70% | 1.884 |
| 6M | 8.39 | 2026-05-19 | +53.87% | 1.286 |
| 1Y | 9.46 | 2025-11-19 | +36.47% | 1.356 |
| 2Y | 46.30 | 2024-11-19 | -72.12% | — |
| 5Y | 113.75 | 2021-11-19 | -88.65% | 1.039 |
BHVN Stock Summary
Biohaven Ltd. (NYSE:BHVN) stock price today is $12.91, and today's volume is 2,323,927. BHVN is down 2.492% today. The 30 day average volume is 3.19M. BHVN market cap is $1.95B with 151.06M shares outstanding.
